FASEB SRC: Immunoreceptors and Immunotherapy

FASEB SRC：免疫受体和免疫疗法

• 批准号: 10462366
• 负责人: Diane Lidke
• 金额: $ 1万
• 依托单位: FEDERATION OF AMER SOC FOR EXPER BIOLOGY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-02 至 2023-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10462366
• 关键词: Address; Autoimmunity; Basic Science; Biology; COVID-19 pandemic; Cell physiology; Cells; Clinic; Collaborations; Communicable Diseases; Communities; Complex; Computer Models; Disease; Educational workshop; Ensure; Environment; Exposure to; Fertilization; Fostering; Funding; Goals; Health; Human; Image; Immune; Immune System Diseases; Immune response; Immune system; Immunity; Immunobiology; Immunologic Receptors; Immunotherapy; Infection; International; Ligands; Louisiana; Malignant Neoplasms; Organ; Participant; Pathology; Persons; Physiology; Play; Request for Applications; Research; Research Personnel; Role; Running; Science; Scientist; Secure; Series; Signal Transduction; Site; Structure-Activity Relationship; Supporting Cell; Technology; Therapeutic; Tissues; Translations; United States National Institutes of Health; antibody engineering; bench to bedside; career; career networking; collaborative environment; efficacious treatment; interdisciplinary collaboration; meetings; novel therapeutic intervention; posters; programmed cell death protein 1; programs; receptor; receptor function; summer research; symposium; translational applications

Abstract The goal of this application is to secure funding for the 2022 FASEB summer research conference (SRC) on “Immunoreceptors and Immunotherapy.” This long-running SRC began in 1987 and has continued to foster a highly interactive community of researchers focused on solving important problems in immunoreceptor and immunotherapy biology. Immunoreceptors play a central role in cancer, autoimmunity and infectious diseases, whilst immunotherapy is the rapidly expanding field focused on meeting these challenges and changing people’s lives in the clinic. The meeting program addresses new directions in the field by featuring the best science related to immune receptor function, immune cell signaling, and the physiology and pathology of immune diseases. We also highlight emerging topics including inhibitory receptors and antibody engineering, along with autoimmunity and immune dysfunction and immunotherapy in cancer. Our speakers represent leaders in the field as well as early- and mid-career investigators. The speakers have been chosen to feature cutting-edge aspects of immunoreceptor and immunotherapy biology, covering the range from basic science to translational applications. The program also includes state-of-the-art technologies in imaging, structural analysis, computational modeling and therapeutic approaches. As such, this meeting brings together scientists from different fields, creating a dynamic and interdisciplinary environment for building networks and developing collaborations. The FASEB SRC provides an ideal format for this meeting, since interactions between participants is guaranteed by the size of the meeting, multiple poster sessions and shared meals. The R13 will support additional opportunities for trainees and young investigators to present at the conference with short talks and poster presentations. Other networking opportunities, including a “meet the expert” luncheon and Career Workshop will further help to foster connections between young investigators and senior researchers. With SRC program, we aim to encourage intensive scientific discussion that promotes new interactions among the international community engaged in immunobiology research.

摘要 此应用程序的目标是为2022年FASE B夏季研究会议(SRC)获得资金 “免疫受体和免疫疗法。”这一长期运行的SRC始于1987年，并继续培养 高度互动的研究人员社区专注于解决免疫受体和 免疫治疗生物学。免疫受体在癌症、自身免疫和传染病中发挥核心作用， 虽然免疫治疗是一个迅速扩大的领域，专注于应对这些挑战并改变人们的 住在诊所里。会议节目介绍了该领域的新方向，展示了与科学有关的最好成果 对免疫受体功能、免疫细胞信号转导、免疫性疾病的生理和病理进行研究。我们 还突出了新出现的话题，包括抑制性受体和抗体工程，以及自身免疫 以及癌症中的免疫功能障碍和免疫治疗。我们的演讲者代表了该领域的领导者以及 职业生涯早期和中期的调查人员。演讲者被选为以最前沿的方面为特色 免疫受体和免疫治疗生物学，涵盖从基础科学到翻译应用的范围。 该计划还包括最先进的技术在成像，结构分析，计算建模 和治疗方法。因此，这次会议汇聚了来自不同领域的科学家，创造了一个 构建网络和开展协作的动态和跨学科环境。FASE B SRC 为本次会议提供了理想的形式，因为参与者之间的交互由 会议，多个海报会议和分享餐点。R13将支持以下更多机会 受训人员和年轻的研究人员将以简短的演讲和海报演示形式出席会议。其他 建立联系的机会，包括“会见专家”午餐会和职业研讨会将进一步有助于促进 年轻研究人员和资深研究人员之间的联系。通过SRC计划，我们的目标是鼓励 密集的科学讨论，促进参与的国际社会之间的新互动 免疫生物学研究。